Hyaluronic Acid Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Hyaluronic Acid Market: By Product (Single-injection, Three-injection, Five-injection), By Route of administration (Oral, Parenteral), By Application (Ophthalmic surgery, Osteoarthritis, Dermal fillers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global hyaluronic acid market size valued USD 8.04 billion in 2020 and expected to reach USD 13.02 billion by 2027, at a CAGR of 8.6% during the forecast period 2021-2027. Hyaluronic acid is a substance that is naturally present in the human body. The higher concentration of the hyaluronic acid is present in the fluids in the eyes and joints. The hyaluronic acid is used in various treatments such as joint disorders, including osteoarthritis. The FDA has approved the use of hyaluronic acid during certain eye surgeries such as cataract removal, corneal transplantation, and repair of a detached retina and other eye injuries. Hyaluronic acid is also used in cosmetic treatments.

Hyaluronic Acid Market

MARKET SUMMARY
-
8.6%
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 8.6%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

Hyaluronic Acid Market

  • The report on global hyaluronic acid market gives historical, current and future market sizes (US$ Bn) based on route of administration, application, distribution channel and region.
  • hyaluronic acid market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Alcon, Inc
  • Allergan, Inc.
  • Ferring Pharmaceuticals, Inc.
  • Fidia Farmaceutici SpA
  • GALDERMA S.A.
Hyaluronic Acid Market

Drivers And Restraints

The increasing geriatric population considerable increases in prevalence of diseases such ulcers, eye diseases and osteoarthritis is likely to drive the growth of the hyaluronic acid market. The growing use of the hyaluronic acid for the treatments such as dry eyes, mouth sores and increasing popularity of the non-surgical procedures with cost-effectiveness expected to drive the growth of the hyaluronic acid market. The non-surgical procedures in aesthetics include botulinum toxin, dermal fillers, laser treatments, chemical peels, and microdermabrasion. The hyaluronic acid injection heals damage caused by scars, wounds, lines. The rising demand for the hyaluronic acid for cosmetic treatments and usage of the hyaluronic acid surfaces in various cardiovascular implants, such as stents and vascular grafts is also driving the growth of the hyaluronic acid market. However, the higher cost of the hyaluronic acid products is likely to hamper the growth of the market.


North-America got significant share

Hyaluronic Acid Market

Geographically, global hyaluronic acid market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is the dominant market in global hyaluronic acid market. Owing to the rising geriatric population and growing awareness about the cost-effective non-surgical procedures is driving the aesthetics market in the region. The Asia Pacific is expected to be the fastest growing region during the forecast period. The increasing geriatric population in the countries of China and Japan provides a large patient pool for the hyaluronic acid treatment in various segments such as osteoarthritis and age related skin issues. Increasing awareness about applications of hyaluronic acid products and its efficacy is also adding fuel to the hyaluronic acid market in this region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Hyaluronic Acid Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Alcon, Inc (U.S)
  • Allergan, Inc. (Ireland)
  • Ferring Pharmaceuticals, Inc. (Switzerland)
  • Fidia Farmaceutici SpA (Italy)
  • GALDERMA S.A. (Switzerland)
  • Hyaltech Ltd (UK)
  • Anika Therapeutics, Inc (U.S)
  • LifeCore Biomedical LLC (U.S)
  • Salix Pharmaceuticals, Inc. (U.S)
  • Smith & Nephew plc (UK)

Description

The global hyaluronic acid market size valued USD 8.04 billion in 2020 and expected to reach USD 13.02 billion by 2027, at a CAGR of 8.6% during the forecast period 2021-2027. Hyaluronic acid is a substance that is naturally present in the human body. The higher concentration of the hyaluronic acid is present in the fluids in the eyes and joints. The hyaluronic acid is used in various treatments such as joint disorders, including osteoarthritis. The FDA has approved the use of hyaluronic acid during certain eye surgeries such as cataract removal, corneal transplantation, and repair of a detached retina and other eye injuries. Hyaluronic acid is also used in cosmetic treatments.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX